Leap2 cDNA ORF clone, Rattus norvegicus(Norway rat)

The following Leap2 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the Leap2 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID Accession No. Definition **Vector *Turnaround time Price (USD) Select
ORa42004 NM_001126081.1
Latest version!
Rattus norvegicus liver-expressed antimicrobial peptide 2 (Leap2), mRNA. pcDNA3.1-C-(k)DYK or customized vector 7-9 $69.30
$99.00

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.

  • Reference Sequences (Refseq)
    CloneID ORa42004
    Clone ID Related Accession (Same CDS sequence) NM_001126081.1
    Accession Version NM_001126081.1 Latest version! Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 189bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2013-04-17
    Organism Rattus norvegicus(Norway rat)
    Product liver-expressed antimicrobial peptide 2 precursor
    Comment Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence was derived from AY310147.1. On or before Apr 30, 2008 this sequence version replaced XM_001073879.1, XM_573087.2. ##Evidence-Data-START## Transcript exon combination :: AY310147.1 [ECO:0000332] ##Evidence-Data-END##

    1
    61
    121
    181
    ATGCTACAGC TAAAACTCTT TGCAGTGCTT CTGACTTGCC TGCTGCTGCT GGGCCAGGAG 
    CTTGTCCACG TTCATCTGAG AGCTTTCTCC ATATTTAAGG ATGATGATTC TGCTGAGCTG
    ATCAATGACA GCAAGGAGAG GCGCATGCAG ACATTCCTGA AAATCAACTT CTTAAATGTT
    AGCAATTGA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_001119553.1
    CDS41..229
    Translation

    Target ORF information:

    RefSeq Version NM_001126081.1
    Organism Rattus norvegicus(Norway rat)
    Definition Rattus norvegicus liver-expressed antimicrobial peptide 2 (Leap2), mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_001126081.1

    ORF Insert Sequence:

    1
    61
    121
    181
    ATGCTACAGC TAAAACTCTT TGCAGTGCTT CTGACTTGCC TGCTGCTGCT GGGCCAGGAG 
    CTTGTCCACG TTCATCTGAG AGCTTTCTCC ATATTTAAGG ATGATGATTC TGCTGAGCTG
    ATCAATGACA GCAAGGAGAG GCGCATGCAG ACATTCCTGA AAATCAACTT CTTAAATGTT
    AGCAATTGA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

  • PubMed

    Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
    Proceedings of the National Academy of Sciences of the United States of America99(26)16899-903(2002 Dec)
    Strausberg RL,Feingold EA,Grouse LH,Derge JG,Klausner RD,Collins FS,Wagner L,Shenmen CM,Schuler GD,Altschul SF,Zeeberg B,Buetow KH,Schaefer CF,Bhat NK,Hopkins RF,Jordan H,Moore T,Max SI,Wang J,Hsieh F,Diatchenko L,Marusina K,Farmer AA,Rubin GM,Hong L,Stapleton M,Soares MB,Bonaldo MF,Casavant TL,Scheetz TE,Brownstein MJ,Usdin TB,Toshiyuki S,Carninci P,Prange C,Raha SS,Loquellano NA,Peters GJ,Abramson RD,Mullahy SJ,Bosak SA,McEwan PJ,McKernan KJ,Malek JA,Gunaratne PH,Richards S,Worley KC,Hale S,Garcia AM,Gay LJ,Hulyk SW,Villalon DK,Muzny DM,Sodergren EJ,Lu X,Gibbs RA,Fahey J,Helton E,Ketteman M,Madan A,Rodrigues S,Sanchez A,Whiting M,Madan A,Young AC,Shevchenko Y,Bouffard GG,Blakesley RW,Touchman JW,Green ED,Dickson MC,Rodriguez AC,Grimwood J,Schmutz J,Myers RM,Butterfield YS,Krzywinski MI,Skalska U,Smailus DE,Schnerch A,Schein JE,Jones SJ,Marra MA,